Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 551–600 of 694 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01393093	Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas(TACE-KMG)	unknown	N/A	2,840	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Jun 12, 2017	clinicaltrials
NCT03178929	Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma	unknown	N/A	207	Beijing Insight Science & Technology Co. Ltd.OTHER	0